All Research Papers Published In ESMO Open

Research Article
10.1016/j.esmoop.2026.107733

Pembrolizumab combined with nab-paclitaxel and platinum in recurrent/metastatic HNSCC: efficacy, safety, and survival predictive model.

May 19, 2026
ESMO open
L Tang + 8 more +8

Research Article
10.1016/j.esmoop.2026.106963

Clinicopathologic characteristics and genomic profiling of HER2-low advanced gastric or gastroesophageal junction cancer.

May 13, 2026
ESMO open
C K Lee + 11 more +11

Research Article
10.1016/j.esmoop.2026.106908

Compartment-specific immune and tumor markers associated with clinical outcomes in patients with and without sarcomatoid/rhabdoid renal cell carcinoma treated with ipilimumab and nivolumab.

May 01, 2026
ESMO open
N Savion-Gaiger + 9 more +9

Research Article
10.1016/j.esmoop.2026.106941

Efficacy and safety of regorafenib in patients with advanced pretreated melanoma: results of the RegoMel phase II clinical trial.

Apr 01, 2026
ESMO open
I Dirven + 21 more +21

Research Article
10.1016/j.esmoop.2026.106923

New prognostic and predictive scoring systems for colorectal cancer liver metastases.

Apr 01, 2026
ESMO open
F Salvà + 15 more +15

Research Article
10.1016/j.esmoop.2026.106318

11MO First disclosure of efficacy and safety data for YL202/BNT326 (HER3 ADC) from a phase II trial in patients (pts) with non-small cell lung cancer (NSCLC)

Apr 01, 2026
ESMO Open
H Liu + 17 more +17

Addendum
10.1016/j.esmoop.2026.106919

Corrigendum to 'Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer': [ESMO Open. Volume 11, Issue 2, February 2026, 106057

Apr 01, 2026
ESMO open
J B Lee + 13 more +13

Research Article
10.1016/j.esmoop.2026.106664

352P Development of the AO spinal metastasis staging (SMS) referral tool: An international multidisciplinary expert panel and survey study

Mar 17, 2026
ESMO Open
R.h Kuijten + 13 more +13

Research Article
10.1016/j.esmoop.2026.106817

502P Transcriptomic classification of lung adenocarcinoma

Mar 17, 2026
ESMO Open
Nicolas Poulain + 5 more +5

Research Article
10.1016/j.esmoop.2026.106314

7MO Becotarug (JMT101) and osimertinib (Osi) in patients (pts) with platinum-pretreated EGFR exon 20 insertion-mutated (ex20ins) non-small cell lung cancer (NSCLC): Final overall survival (OS) and subgroup analyses from the BECOME phase II study

Mar 17, 2026
ESMO Open
L Zhang + 19 more +19